Clinical Trials Browser

Unknown × Interventional × dinutuximab × Clear all

NCT02743429 2021-10-04

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Phase 2 Unknown

Neuroblastoma